Showing results (91-100 of 188) with videos related to
Sort By:
Pageof 19
Blood|November 25, 2010
Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLLShih-Shih Chen, Rainer Claus, David M Lucas, et al.British Journal of Haematology|July 27, 2012
Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemiaSamantha M Jaglowski, Amy S Ruppert, Nyla A Heerema, et al.Leukemia & Lymphoma|August 29, 2014
Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplantGalena Salem, Amy S Ruppert, Patrick Elder, et al.Cancer Chemotherapy and Pharmacology|February 23, 2013
Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancerRachel M Layman, Amy S Ruppert, Melinda Lynn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2022
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance)Ann S LaCasce, Travis Dockter, Amy S Ruppert, et al.Proceedings of the National Academy of Sciences of the United States of America|March 10, 2004
Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genesClaudia D Baldus, Sandya Liyanarachchi, Krzysztof Mrózek, et al.Leukemia & Lymphoma|February 29, 2012
Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B studyGerard Lozanski, Amy S Ruppert, Nyla A Heerema, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2012
Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studiesJennifer A Woyach, Amy S Ruppert, Kanti Rai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B StudyPeter Paschka, Guido Marcucci, Amy S Ruppert, et al.British Journal of Haematology|December 2, 2017
A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factorKerry A Rogers, Ying Huang, Amy S Ruppert, et al.Pageof 19